Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke

High blood pressure (BP), pulse pressure (PP), and rate pressure product (RPP) areeach associated independently with a poor outcome in acute ischemic stroke. Whereas nitric oxide (NO) donors, such as glyceryl trinitrate (GTN), lower blood pressure in acute ischemic stroke, their effect on other hem...

Full description

Bibliographic Details
Main Authors: Gray, Laura J., Sprigg, Nikola, Rashid, Parveen, Willmot, Mark, Bath, Philip M.W.
Format: Article
Published: Elsevier 2006
Online Access:https://eprints.nottingham.ac.uk/464/
_version_ 1848790416064774144
author Gray, Laura J.
Sprigg, Nikola
Rashid, Parveen
Willmot, Mark
Bath, Philip M.W.
author_facet Gray, Laura J.
Sprigg, Nikola
Rashid, Parveen
Willmot, Mark
Bath, Philip M.W.
author_sort Gray, Laura J.
building Nottingham Research Data Repository
collection Online Access
description High blood pressure (BP), pulse pressure (PP), and rate pressure product (RPP) areeach associated independently with a poor outcome in acute ischemic stroke. Whereas nitric oxide (NO) donors, such as glyceryl trinitrate (GTN), lower blood pressure in acute ischemic stroke, their effect on other hemodynamic measures is not known. We performed a systematic review of the effects of NO donors on systemic hemodynamic measures in patients with acute/subacute stroke. Randomized controlled trials were identified from searches of the Cochrane Library, Pubmed, and Embase. Information on hemodynamic measures, including systolic BP (SBP), diastolic BP (DBP), and heart rate, were assessed, and hemodynamic derivatives of these were calculated: PP (PP SBP DBP), mean arterial pressure (MAP DBP PP/3), mid blood pressure (MBP (SBP DBP)/2), pulse pressure index (PPI PP/MAP), and RPP (RPP SBP HR). The effect of treatment on hemodynamic measures was calculated as the weighted mean difference (WMD) between treated and control groups with adjustment for baseline. Results: Three trials involving 145 patients were identified; 93 patients received the NO donor, GTN, and 52 control. As compared with placebo, GTN significantly reduced SBP (WMD -9.80 mmHg, p< 0.001), DBP (WMD -4.43 mmHg, p<0.001), MAP (WMD -6.41 mmHg, p< 0.001), MBP (WMD -7.33 mmHg,p<0.001), PP (WMD -6.11 mmHg, p<0.001 ) and PPI (WMD -0.03, p=0.04 ). 3 GTN increased HR (WMD +3.87 bpm, p<0.001) and non-significantly lowered RPP (WMD -323 mmHg.bpm, p=0.14). Conclusion: The NO donor GTN reduces BP, PP and other derivatives in acute and subacute stroke whilst increasing heart rate.
first_indexed 2025-11-14T18:12:16Z
format Article
id nottingham-464
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T18:12:16Z
publishDate 2006
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling nottingham-4642024-08-15T15:33:29Z https://eprints.nottingham.ac.uk/464/ Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke Gray, Laura J. Sprigg, Nikola Rashid, Parveen Willmot, Mark Bath, Philip M.W. High blood pressure (BP), pulse pressure (PP), and rate pressure product (RPP) areeach associated independently with a poor outcome in acute ischemic stroke. Whereas nitric oxide (NO) donors, such as glyceryl trinitrate (GTN), lower blood pressure in acute ischemic stroke, their effect on other hemodynamic measures is not known. We performed a systematic review of the effects of NO donors on systemic hemodynamic measures in patients with acute/subacute stroke. Randomized controlled trials were identified from searches of the Cochrane Library, Pubmed, and Embase. Information on hemodynamic measures, including systolic BP (SBP), diastolic BP (DBP), and heart rate, were assessed, and hemodynamic derivatives of these were calculated: PP (PP SBP DBP), mean arterial pressure (MAP DBP PP/3), mid blood pressure (MBP (SBP DBP)/2), pulse pressure index (PPI PP/MAP), and RPP (RPP SBP HR). The effect of treatment on hemodynamic measures was calculated as the weighted mean difference (WMD) between treated and control groups with adjustment for baseline. Results: Three trials involving 145 patients were identified; 93 patients received the NO donor, GTN, and 52 control. As compared with placebo, GTN significantly reduced SBP (WMD -9.80 mmHg, p< 0.001), DBP (WMD -4.43 mmHg, p<0.001), MAP (WMD -6.41 mmHg, p< 0.001), MBP (WMD -7.33 mmHg,p<0.001), PP (WMD -6.11 mmHg, p<0.001 ) and PPI (WMD -0.03, p=0.04 ). 3 GTN increased HR (WMD +3.87 bpm, p<0.001) and non-significantly lowered RPP (WMD -323 mmHg.bpm, p=0.14). Conclusion: The NO donor GTN reduces BP, PP and other derivatives in acute and subacute stroke whilst increasing heart rate. Elsevier 2006-11 Article PeerReviewed Gray, Laura J., Sprigg, Nikola, Rashid, Parveen, Willmot, Mark and Bath, Philip M.W. (2006) Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke. Journal of Stroke and Cerebrovascular Disease, 15 (6). pp. 245-249.
spellingShingle Gray, Laura J.
Sprigg, Nikola
Rashid, Parveen
Willmot, Mark
Bath, Philip M.W.
Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke
title Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke
title_full Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke
title_fullStr Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke
title_full_unstemmed Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke
title_short Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke
title_sort effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke
url https://eprints.nottingham.ac.uk/464/